I
Ismael Calandri
Researcher at University of Buenos Aires
Publications - 52
Citations - 638
Ismael Calandri is an academic researcher from University of Buenos Aires. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 7, co-authored 42 publications receiving 272 citations.
Papers
More filters
Journal ArticleDOI
World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
Miia Kivipelto,Francesca Mangialasche,Francesca Mangialasche,Heather M. Snyder,Ricardo F. Allegri,Sandrine Andrieu,Hidenori Arai,Laura D. Baker,Sylvie Belleville,Henry Brodaty,Sonia Maria Dozzi Brucki,Ismael Calandri,Paulo Caramelli,Christopher C. Chen,Howard Chertkow,Effie Chew,Seong Hye Choi,Neerja Chowdhary,Lucia Crivelli,Rafael de la Torre,Yifeng Du,Tarun Dua,Mark A. Espeland,Howard Feldman,Howard Feldman,Maris Hartmanis,Tobias Hartmann,Megan Heffernan,Christiani Jeyakumar Henry,Chang H. Hong,Krister Håkansson,Takeshi Iwatsubo,Jee H. Jeong,Gustavo Jimenez-Maggiora,Edward H. Koo,Lenore J. Launer,Jenni Lehtisalo,Jenni Lehtisalo,Francisco Lopera,Pablo Martinez-Lage,Ralph N. Martins,Ralph N. Martins,Lefkos T. Middleton,Jose Luis Molinuevo,Manuel Montero-Odasso,So Y. Moon,Kristal Morales-Perez,Ricardo Nitrini,Haakon B. Nygaard,Yoo K. Park,Markku Peltonen,Markku Peltonen,Chengxuan Qiu,Chengxuan Qiu,Yakeel T. Quiroz,Yakeel T. Quiroz,Rema Raman,Naren P. Rao,Vijayalakshmi Ravindranath,Anna Rosenberg,Takashi Sakurai,Rosa M. Salinas,Philip Scheltens,Gustavo Sevlever,Hilkka Soininen,Ana Luisa Sosa,Claudia K. Suemoto,Mikel Tainta-Cuezva,Lina Velilla,Yongxiang Wang,Rachel A. Whitmer,Xin Xu,Lisa J. Bain,Alina Solomon,Alina Solomon,Tiia Ngandu,Tiia Ngandu,Maria C. Carrillo +77 more
TL;DR: The WW‐FINGERS aims to harmonize and adapt multidomain interventions across various countries and settings, to facilitate data sharing and analysis across studies, and to promote international joint initiatives to identify globally implementable and effective preventive strategies.
Journal ArticleDOI
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia
David Bergeron,David Bergeron,Maria Luisa Gorno-Tempini,Gil D. Rabinovici,Miguel A. Santos-Santos,William W. Seeley,Bruce L. Miller,Yolande A.L. Pijnenburg,M. Antoinette Keulen,Colin Groot,Bart N.M. van Berckel,Wiesje M. van der Flier,Philip Scheltens,Jonathan D. Rohrer,Jason D. Warren,Jonathan M. Schott,Nick C. Fox,Raquel Sánchez-Valle,Oriol Grau-Rivera,Ellen Gelpi,Harro Seelaar,Janne M. Papma,John C. van Swieten,John R. Hodges,John R. Hodges,John R. Hodges,Cristian E. Leyton,Olivier Piguet,Olivier Piguet,Olivier Piguet,Emily Rogalski,Emily Rogalski,M.-Marsel Mesulam,Lejla Koric,Kristensen Nora,Jeéreémie Pariente,Bradford C. Dickerson,Ian R. A. Mackenzie,Ging-Yuek Robin Hsiung,Serge Belliard,David J. Irwin,David A. Wolk,Murray Grossman,Matthew Jones,Jennifer M. Harris,David G. Mann,Julie S. Snowden,Patricio Chrem-Méndez,Ismael Calandri,Alejandra A. Amengual,Carole Miguet-Alfonsi,Eloi Magnin,Giuseppe Magnani,Roberto Santangelo,Vincent Deramecourt,Florence Pasquier,Niklas Mattsson,Christer Nilsson,Oskar Hansson,Julia Keith,Mario Masellis,Sandra E. Black,Jordi A. Matías-Guiu,María Nieves Cabrera-Martín,Claire Paquet,Julien Dumurgier,Marc Teichmann,Marie Sarazin,Marie Sarazin,Michel Bottlaender,Michel Bottlaender,Bruno Dubois,Christopher C. Rowe,Victor L. Villemagne,Rik Vandenberghe,Elias Granadillo,Edmond Teng,Mario F. Mendez,Philipp T. Meyer,Lars Frings,Alberto Lleó,Rafael Blesa,Juan Fortea,Sang Won Seo,Janine Diehl-Schmid,Timo Grimmer,Kristian Steen Frederiksen,Pascual Sánchez-Juan,Gaël Chételat,Willemijn J. Jansen,Rémi W. Bouchard,Robert Laforce,Pieter Jelle Visser,Rik Ossenkoppele,Rik Ossenkoppele +94 more
TL;DR: To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in primary progressive aphasia (PPA) variants, PET/CSF biomarkers are used.
Journal ArticleDOI
Neurological Events Reported after COVID‐19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
Jennifer A. Frontera,Arina Tamborska,Mohamed Fahmy Doheim,David García-Azorín,Haşim Gezegen,Alla Guekht,Abdul Hanif Khan Yusof Khan,Michele Santacatterina,James J. Sejvar,Kiran T. Thakur,Erica Westenberg,Andrea Sylvia Winkler,Ettore Beghi,Ricardo F. Allegri,Betül Baykan,Lana Blinc,Abhilasha P Boruah,Maja Bresjanac,Yuliya Bryzgalova,Ismael Calandri,Guillermo Delgado-García,Rashmi Devaraj,Simon Faissner,Fan Kee Hoo,Jessica Hunter,Jeyanthan Charles James,Nana Yaa Kyei‐Frimpong,Suzannah Lant,Nicholas Mulchan,Manjunath Netravathi,Svetlana Pikovskaya,Nihara Abdul Rasheed,Ahmed S. Safwat,Parthasarathy Satishchandra,Ali S. Shalash,Nina Singh,Marianna Spatola,Vivian Ssonko,Lindsay G. Tetreault,Gaja Cvejić Vidali,J Weng,Elyce Warburton,T. Welte,Tissa Wijeratne,Doris Yan Xia,D. Zhuravlev,M S Zinchuk +46 more
TL;DR: To identify the rates of neurological events following administration of mRNA (Pfizer, Moderna) or adenovirus vector (Janssen) vaccines in the U.S.
Journal ArticleDOI
Anti-inflammatory effects of melatonin in multiple sclerosis.
TL;DR: Data is reviewed on the effects of melatonin on immune processes relevant for MS and its therapeutic potential, suggesting that melatonin‐triggered signaling pathways are potential targets for therapeutic intervention.
Journal ArticleDOI
Impact of Social Isolation on People with Dementia and Their Family Caregivers.
Lílian Viana Dos Santos Azevedo,Ismael Calandri,Andrea Slachevsky,Héctor Gastón Graviotto,Maria Carolina Santos Vieira,Caíssa Bezerra de Andrade,Adriana Peredo Rossetti,Alana Barroso Generoso,Karoline Carvalho Carmona,Ludmilla Aparecida Cardoso Pinto,Marcos Sorbara,Alejandra Pinto,Tania Guajardo,Loreto Olavarria,Daniela Thumala,Lucia Crivelli,Ludmila Vivas,Ricardo F. Allegri,Maira Tonidandel Barbosa,Cecilia Serrano,Claudia Miranda-Castillo,Claudia Miranda-Castillo,Paulo Caramelli +22 more
TL;DR: In this article, the authors investigated the impacts of social isolation due to the COVID-19 pandemic on individuals with dementia and their family caregivers, which can be manifested as various behavioral and clinical symptoms.